NEWS FROM THE ECF

Investigator’s signature on electronic Case Report Forms (eCRFs)

Best Practices

There is increased scrutiny by regulatory agencies on the collection of investigator’s signature as evidence of the overall oversight on the eCRF data reported to the sponsor.
Due to different interpretation on the timing and frequency for the collection of the investigator’ssignature, an eCF Task Force has been formed to identify best practices that are based on the compliance to regulatory requirements and on risks such as reputation, credibility, legal liability of the data being used by the sponsor. The intent of this document is to provide a framework for individuals’ risk‐based decisions and best practices for implementing solutions for investigators’ signature collection on data reported to sponsor.

Documents to download

Print
Tags:
Rate this article:
No rating
«November 2026»
MonTueWedThuFriSatSun
2627282930311
2345678
910

eCF Webinar November: FDA warning letters for audit trail analytics

FDA warning letters tell us what went wrong, but what could your audit trail analytics program have caught earlier? Join our upcoming webinar for a practical, in-depth look at an FDA warning letter and learn how to identify missed signals, uncover blind spots, and strengthen your audit trail review program.

Read more
1112131415
16171819202122
23242526272829
30123456